Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

Christine Federspiel; Theis S Itenov; Katrin Thormar; Morten H Bestle

Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

Translated title of the contribution: Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients

Christine Federspiel, Theis S Itenov, Katrin Thormar, Morten H Bestle

Department of Clinical Medicine

Research output: Contribution to journal › Journal article › Research › peer-review

1 Citation (Scopus)

Abstract

Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.

Translated title of the contribution	Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients
Original language	Danish
Article number	V07150610
Journal	Ugeskrift for Laeger
Volume	177
Issue number	50
Pages (from-to)	2-6
Number of pages	5
ISSN	0041-5782
Publication status	Published - 7 Dec 2015

Access to Document

http://ugeskriftet.dk.ep.fjernadgang.kb.dk/videnskab/V07150610

Cite this

@article{206cccd6369d40efb4e62666eed3cf71,

title = "Begr{\ae}nset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter",

abstract = "Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.",

author = "Christine Federspiel and Itenov, {Theis S} and Katrin Thormar and Bestle, {Morten H}",

year = "2015",

month = dec,

day = "7",

language = "Dansk",

volume = "177",

pages = "2--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "50",

}

TY - JOUR

T1 - Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

AU - Federspiel, Christine

AU - Itenov, Theis S

AU - Thormar, Katrin

AU - Bestle, Morten H

PY - 2015/12/7

Y1 - 2015/12/7

N2 - Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.

AB - Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.

M3 - Tidsskriftartikel

C2 - 26651912

VL - 177

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 50

M1 - V07150610

ER -